Triclofos Sodium Dosing for 1-Year-Old Infant
For a 1-year-old infant, the recommended dose of triclofos sodium syrup is 75-80 mg/kg administered orally for procedural sedation.
Dosing Recommendations
Based on the available evidence, the standard dosing approach for triclofos sodium in infants is:
- Primary dose: 75-80 mg/kg orally 1, 2, 3
- Onset of sedation: Typically 25-45 minutes 1, 3
- Duration of effect: Approximately 35 minutes 3
The most robust evidence comes from a 2021 observational study that specifically evaluated 80 mg/kg in children under 5 years (mean age 23.4 months), demonstrating successful sedation in 87.7% of cases with no major adverse events 1. This dose has been validated across multiple studies for non-painful procedures including EEG, audiometry, and ophthalmologic examinations 3, 4.
Practical Administration
If initial sedation is inadequate:
- Additional doses of 0.5 mg/kg can be administered every 5 minutes
- Maximum wait time: 60 minutes from initial dose
- If Ramsay sedation score remains ≤4 after 60 minutes, consider the procedure a failure and use alternative sedation 1
Safety Profile
The safety data for this age group is reassuring:
- No cases of apnea reported in large cohorts 3
- Desaturation (≤90%): 0.2% 3
- Vomiting: 0.35% 3
- No hemodynamic instability 3
Importantly, triclofos appears safe even in children with neurocognitive disorders, with 41.2% of one study cohort having conditions like seizures, hypotonia, or developmental delay without increased adverse events 3.
Important Caveats
Monitor continuously during sedation:
- Heart rate and oxygen saturation throughout the procedure
- Ensure controlled, monitored environment with appropriate resuscitation equipment available
Rare adverse effects to watch for:
- Non-epileptic pedaling-like movements (reported in one case at 80 mg/kg dose) 5
- These movements are benign, can be arrested by manual restraint, and resolve within 2 hours
Formulation note: Triclofos is typically available as a syrup containing 100 mg/mL, making it palatable for oral administration in young children 2.
The 75-80 mg/kg dose represents the optimal balance between efficacy and safety for this age group, with success rates approaching 90% and minimal risk of serious adverse events when administered in an appropriate clinical setting.